PDS BiotechnologyFRA:EU6 +1.04%33 Pretax Margin % is % as of Mar. 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, PDS Biotechnology ranks worse than 105932.1% on this metric.
The historical rank and industry rank for PDS Biotechnology's Pretax Margin % or its related term are showing as below:
FRA:EU6's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5 * Ranked among companies with meaningful Pretax Margin % only.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
PDS Biotechnology Pretax Margin % Related Terms
PDS Biotechnology Pretax Margin % Historical Data
* Premium members only.
The historical data trend for PDS Biotechnology's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:EU6 vs LTRN, AURX, VERU: Pretax Margin % Comparison
For the Biotechnology subindustry, PDS Biotechnology's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDS Biotechnology Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where PDS Biotechnology's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PDS Biotechnology (FRA:EU6) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PDS Biotechnology and its competitors. According to the industry distribution chart, PDS Biotechnology ranks #999999 out of 944 companies in the Biotechnology industry.
Is PDS Biotechnology's Pretax Margin % too high?
PDS Biotechnology's current Pretax Margin % is %. Based on the distribution chart, PDS Biotechnology ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PDS Biotechnology has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's Pretax Margin % compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #999999 out of 944 companies for Pretax Margin %. This places PDS Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current Pretax Margin % of %. The current Pretax Margin % is %. PDS Biotechnology's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
33GF Score
Get the complete analysis for FRA:EU6
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EU6 has been successfully added to your 
